#  @DegStonks DegenerateStonks DegenerateStonks posts on X about play, company, strong, this is the most. They currently have [------] followers and [--] posts still getting attention that total [-----] engagements in the last [--] hours. ### Engagements: [-----] [#](/creator/twitter::2015517828900646912/interactions)  - [--] Week [-----] -61% ### Mentions: [--] [#](/creator/twitter::2015517828900646912/posts_active)  ### Followers: [------] [#](/creator/twitter::2015517828900646912/followers)  - [--] Week [--] +44% ### CreatorRank: [---------] [#](/creator/twitter::2015517828900646912/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [cryptocurrencies](/list/cryptocurrencies) [automotive brands](/list/automotive-brands) [countries](/list/countries) [technology brands](/list/technology-brands) **Social topic influence** [play](/topic/play), [company](/topic/company), [strong](/topic/strong), [this is](/topic/this-is), [mining](/topic/mining), [growth](/topic/growth), [$cifr](/topic/$cifr), [we are](/topic/we-are), [solar](/topic/solar), [liquidity](/topic/liquidity) **Top accounts mentioned or mentioned by** [@capitansteveo](/creator/undefined) [@ckcapitalxx](/creator/undefined) [@trevorhunstoc](/creator/undefined) [@kurtgibbonsx](/creator/undefined) [@ap_redcoldriver](/creator/undefined) [@juggmanguwop](/creator/undefined) [@hurdleratepod](/creator/undefined) [@strive](/creator/undefined) [@strategy](/creator/undefined) [@t1energy](/creator/undefined) [@thomasjames1](/creator/undefined) [@electroncowboy](/creator/undefined) [@chamath](/creator/undefined) [@crusoeai](/creator/undefined) [@futuristlens](/creator/undefined) [@grok](/creator/undefined) [@investincintel](/creator/undefined) [@euphoriafi](/creator/undefined) [@red81110245](/creator/undefined) [@trevor_hun_stoc](/creator/undefined) **Top assets mentioned** [Cipher Mining Inc. Common Stock (CIFR)](/topic/$cifr) [Bitcoin (BTC)](/topic/bitcoin) [Rocket Lab USA, Inc. Common Stock (RKLB)](/topic/$rklb) [Faraday Future Intelligent Electric Inc. Common Stock (FFAI)](/topic/$ffai) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) [AB (prev. Newton) (AB)](/topic/$ab) [FTC Solar, Inc. (FTCI)](/topic/$ftci) [retard to retired (R/R)](/topic/$rr) [Carpenter Technology Corp (CRS)](/topic/$crs) [Kroger Co (KR)](/topic/kroger) [Bitfarms Ltd. (BITF)](/topic/bitfarms) [Uranium Energy Corp. (UEC)](/topic/$uec) ### Top Social Posts Top posts by engagements in the last [--] hours "$AB Degenerate Stonks Score: [--] / [--] Tier: Durable but Unexciting AllianceBernstein is a cash-generating asset manager with low dilution risk and a valuation focused on income and stability. This is not a hyper-growth story but it is a survivable one. Recent leadership changes and reduced short interest support sentiment but upside is incremental rather than explosive. New attention may fall on #AllianceBernstein because of recently disclosed positions taken by #NancyPelosi. This score reflects durability and risk; not price targets or advice." [X Link](https://x.com/DegStonks/status/2015828575161561524) 2026-01-26T16:45Z [--] followers, [----] engagements "Well well well $ONCY. My how the turns have tabled. DegenerateStonks Scorecard: 13/20 When we first scored this in January we gave them a score of [--] and mentioned the risk associated with them. But the story was strong. Fast forward a bit and here we are. In case you aren't familiar with them; Oncolytics Biotech is a clinical-stage biotech developing REQORSA (oncolytic virus therapy) for non-small cell lung cancer (NSCLC) with Phase [--] Acclaim-1 data readout Q1 [----] and Acclaim-3 expansion (interim H2 2026). What seems to be fueling this jump in price is a recent cluster of insider buys (Feb" [X Link](https://x.com/anyuser/status/2022411923724066952) 2026-02-13T20:45Z [--] followers, [---] engagements "Love the work y'all do over there. Been a great inspiration for a lot of folks. $AB scores as durable not explosive from how we're looking at it. They have strong cash flows low dilution risk and a valuation built around income rather than growth. The trade fits a stability profile more than a momentum or speculative one. Strong fundamentals even if a 'boring' company. There's a reason elected officials go after stocks like this. https://twitter.com/i/web/status/2015827508998889562 https://twitter.com/i/web/status/2015827508998889562" [X Link](https://x.com/DegStonks/status/2015827508998889562) 2026-01-26T16:41Z [--] followers, [----] engagements "@JuggManGuwop @HurdleRatePod @strive @Strategy And that's what makes them so darn interesting. =)" [X Link](https://x.com/DegStonks/status/2016734956035182787) 2026-01-29T04:47Z [--] followers, [--] engagements "$INTC score is held back primarily by two areas: Financial Trajectory (2/4) Product & Execution (2/4) Financial Trajectory: Intels recent results show improvement but managements cautious [----] outlook highlights that recovery is still uneven. Revenue and profitability are stabilizing from a weak period not accelerating from strength. This is a transition phase not a confirmed growth cycle. Product & Execution: Intels roadmap and foundry ambitions are credible but execution consistency remains the key risk. The company is mid-turnaround requiring sustained delivery across manufacturing and" [X Link](https://x.com/DegStonks/status/2017633221010461166) 2026-01-31T16:17Z [--] followers, [--] engagements "Hard agree on that. Here's one we recently scored. $FTCI #solarindustries #solarpower Solar is not A source of energy it is THE source of energy Solar is not A source of energy it is THE source of energy" [X Link](https://x.com/DegStonks/status/2017726683629949024) 2026-01-31T22:28Z [--] followers, [---] engagements "$FTCI FTC Solar is in an interesting position to deliver on legitimate potential. They provide single-axis solar trackers software (Voyager) and engineering services for utility-scale projects optimizing yield in large solar farms. Not only are they a US-based solar company they also benefit greatly from strong domestic incentives. Recent revenue growth shows real promise on the horizon for investors; strong Q3 [----] revenue of $26M (+157% YoY beat guidance). This is their first positive gross margin since [----] (6-7%) and have a backlog of projects worth up to $462M. Q4 guidance was $30-$35M" [X Link](https://x.com/DegStonks/status/2017728285770162614) 2026-01-31T22:34Z [--] followers, [--] engagements "$TE scores strongest in one primary area on the Degenerate Stonks Scorecard: Market & Sector (3/4) Market & Sector: T1 Energy operates in energy and infrastructure-adjacent markets that benefit from long-term structural demand. Electrification power generation and energy security remain durable macro themes. From a top-down perspective the market opportunity itself is real and supportive. This score reflects macro tailwinds not company execution. Strong markets create opportunity. They dont guarantee outcomes. https://twitter.com/i/web/status/2018018761463267503" [X Link](https://x.com/DegStonks/status/2018018761463267503) 2026-02-01T17:49Z [--] followers, [---] engagements "$MP DegenerateStonks Scorecard: 13/20 MP Materials owns and operates Mountain Pass America's only scaled rare earth mine/processor producing NdPr oxide and advancing to full mine-to-magnet integration with its Fort Worth facility (magnets Q1 2026). The narrative focuses on U.S. supply chain resilience amid China dominance with Q4 [----] results due Feb [--] (est. EPS $0.10) but [----] challenges (revenue down 50% Q3 losses) and policy shifts temper momentum. Real-time X sentiment mixed-positive on government stakes (15%) and DoD deals but sell-offs noted amid refining tech concerns. #mpmaterials" [X Link](https://x.com/DegStonks/status/2018824185028710409) 2026-02-03T23:09Z [--] followers, [--] engagements "$NVX DegenerateStonks Scorecard: 10/20 NOVONIX is a battery tech/materials firm developing North America's first synthetic graphite anode production (Riverside facility mass prod [----] for industrial [----] for batteries) with testing equipment/services as cash flow bridge. Narrative: IRA-compliant supply chain for EVs but delays (Panasonic H2 [----] Stellantis termination) pre-revenue status (TTM $5.93M) losses (-$66M) and funding needs amid execution push. X sentiment positive on first-mover edge but volatility concerns. Pre-production stories hinge on milestones. Making the potential real but" [X Link](https://x.com/DegStonks/status/2019103659670520186) 2026-02-04T17:40Z [--] followers, [---] engagements "By being patient and disciplined. This is where knowing what the story is behind a stock and understanding how strong that story is can pay off over the long haul. Here are a few worth keeping an eye on. Especially as the dust begins to settle in certain sectors. $NBIS $RR $VELO https://twitter.com/i/web/status/2019612523167641963 https://twitter.com/i/web/status/2019612523167641963" [X Link](https://x.com/DegStonks/status/2019612523167641963) 2026-02-06T03:22Z [--] followers, [----] engagements "@T1_Energy Seems to be a bright future ahead" [X Link](https://x.com/DegStonks/status/2019618291929739500) 2026-02-06T03:44Z [--] followers, [--] engagements "$FFAI Degenerate Stonks Scorecard: 11/20 We can all agree that robots are cool. Useful (and affordable) robots are even cooler. This one is really interesting and shows real promise and possible utility; but very fragile overall right now. The $10M equity investment from AIxCrypto (AIXC) via SEC agreement (Jan [--] 2026) provides short-term liquidity but introduces explicit dilution risks with anti-dilution true-up shares. Then there is the non-exclusive strategic partnership with AIXC exploring blockchain integration in robotics (e.g. decentralized identity on-chain settlements) which aligns" [X Link](https://x.com/anyuser/status/2019998619022078435) 2026-02-07T04:56Z [--] followers, [---] engagements "@Thomas_james_1 $FFAI & $RR are two others worth a close watch. Depending on your risk appetite" [X Link](https://x.com/DegStonks/status/2020181593953087831) 2026-02-07T17:03Z [--] followers, [---] engagements "$CRS Degenerate Stonks Scorecard: 17/20 Carpenter Technology is a leading producer of premium specialty alloys and materials for aerospace defense medical and energy sectors with a focus on high-performance solutions like titanium and superalloys. The CRS story is one of a resilient materials play benefiting from aerospace/defense tailwinds (e.g. Boeing/GE ramps) with recent Q2 FY2026 beats (revenue $1.1B +19% YoY EPS $1.75 beat estimates) and raised FY2026 EBITDA guidance ($735-775M). There are still cyclical risks remaining such as: modest growth outlook (FY2026 revenue est. $4.2B +8%)" [X Link](https://x.com/anyuser/status/2020221510514844029) 2026-02-07T19:41Z [--] followers, [--] engagements "$GNPX Degenerate Stonks Scorecard: 7/20 Who likes to play in the biotech sandbox Genprex is a clinical-stage gene therapy company developing Oncoprex (REQORSA) for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) with Acclaim-1 Phase [--] data readout targeted Q1 [----] and Acclaim-3 expansion (interim analysis H2 2026). As far as biotech moonshots go this one has FDA Fast Track/Orphan designations but is pre-revenue (no TTM income) with deep losses (-$7.2M Q3 [----] -$25M TTM) cash burn (runway into Q2 [----] post-$3.1M raise) and execution risks amid clinical timelines and" [X Link](https://x.com/anyuser/status/2020229326973858290) 2026-02-07T20:13Z [--] followers, [---] engagements "@CapitanSteveo We wouldn't necessarily view one as being 'safer' than the other due to the speculative nature of their sector but based on the story backing each - we'd give the edge to $CIFR. They are better set up to succeed long-term especially with their recent pivot" [X Link](https://x.com/DegStonks/status/2020241800175448347) 2026-02-07T21:02Z [--] followers, [---] engagements "$CIFR Degenerate Stonks Scorecard: 16/20 Cipher Mining is pivoting from Bitcoin mining to AI/HPC data centers with large-scale colocation deals (e.g. Amazon pre-lease for Black Pearl 300MW Google/others contributing to $8.5B contracted revenue over 10+ years). The new story behind them is a high-conviction AI infrastructure play: recent $2B senior secured notes (Feb 2026) fund Black Pearl completion strong Q3 [----] crypto revenue tripled YoY and HPC ramp targets [----] delivery. Risks still remain however. Legacy mining losses high debt from funding execution on buildouts and valuation" [X Link](https://x.com/anyuser/status/2020242570333339668) 2026-02-07T21:05Z [--] followers, [---] engagements "Seems there may have been a temporary trading app glitch (e.g. seen on Thinkorswim snapping back quickly) not real fundamentals or a setup for a squeeze. Current data shows [-----] to 10M shares available to borrow across brokers with short interest at 40.11M (20.23% of float) and elevated borrow fees ranging 10.57-12.88%. So elevated but not extreme (e.g. not 100% like true squeezes). Short ratio is [--] days to cover implying no immediate pressure. Plus keep in mind that enough people still need to believe in the story enough to keep it going strong." [X Link](https://x.com/DegStonks/status/2020327536958324856) 2026-02-08T02:43Z [--] followers, [---] engagements "@CKCapitalxx $CIFR is an interesting one with this pivot of theirs. It scores well and has a strong story and momentum" [X Link](https://x.com/DegStonks/status/2020360134665392300) 2026-02-08T04:52Z [--] followers, [---] engagements "$JSDA Degenerate Stonks Scorecard: 9/20 Jones Soda is a craft beverage company expanding from premium sodas into cannabis-infused drinks (Mary Jones brand) energy shots and THC gummies/syrups targeting retail growth (e.g. Walmart Kroger expansions). Turnaround stories like this are fascinating. Jones Soda is able to pull at the heart strings of nostalgia with some of their limited edition set releases (such as the Fallout one) and now they've managed to pivot into the cannabis market. They do have some positive momentum with recent Q3 [----] beats (revenue $4.6M +17% YoY gross margin 31.4%) but" [X Link](https://x.com/anyuser/status/2020528550093177288) 2026-02-08T16:02Z [--] followers, [--] engagements "$BITF Degenerate Stonks Scorecard: 10/20 Bitfarms is pivoting from Bitcoin mining to AI/HPC infrastructure with U.S. redomiciliation (planned April [----] rebrand to Keel Infrastructure) strong liquidity ($698M net as of Feb 2026) and HPC site conversions (e.g. Washington 18MW to GB300 GPUs). The story and excitement are around a cost-advantaged (hydro power in Quebec/PA) hybrid play that still facing challenges: postponed guidance rising leverage/capex EBITDA declines liquidity risks (1 year cash runway highlighted) regulatory delays in crypto market structure and operational hurdles in" [X Link](https://x.com/anyuser/status/2020532480428650586) 2026-02-08T16:17Z [--] followers, [---] engagements "@CapitanSteveo Not as high as $CIFR but there's still something here worth following" [X Link](https://x.com/DegStonks/status/2020532710222057618) 2026-02-08T16:18Z [--] followers, [--] engagements "@trevor_hun_stoc Well. Those that are in already are probably pleased. ;-)" [X Link](https://x.com/DegStonks/status/2021210146555285619) 2026-02-10T13:10Z [--] followers, [--] engagements "@Electron_Cowboy @chamath @CrusoeAI What are your thoughts on carbon nanotubes possibly being scalable and cost efficient enough to be a legitimate alternative to copper in the future" [X Link](https://x.com/DegStonks/status/2021605413435666824) 2026-02-11T15:21Z [--] followers, [---] engagements "$RKLB Degenerate Stonks Scorecard: 17/20 Rocket Lab is a space launch and systems company with Electron (small-lift [--] launches in [----] record) and upcoming Neutron (medium-lift maiden flight targeted H1 2026). They have continued to deliver big on their promises and show ongoing durable growth and execution. Some of the major catalysts include record launches $816M U.S. Space Force prime contract (Tranche [--] satellites) defense prime evolution and Space Systems backlog conversion driving margins. Recent Q4 [----] preview points to beatable revenue ($130-140M est.) but Neutron risks (e.g. Stage" [X Link](https://x.com/anyuser/status/2021789634389299265) 2026-02-12T03:33Z [--] followers, [---] engagements "$INDI Degenerate Stonks Scorecard: 15/20 indie Semiconductor designs mixed-signal semiconductors for automotive ADAS in-cabin monitoring and emerging robotics/quantum markets. This is auto-tech with a $7.1B backlog and [----] $800M sales goal plus new emotion3D partnership (Mahindra EVs Feb 2026) and laser diode for quantum/automotive. Recent Q4 [----] earnings Feb [--] call pending but Q3 [----] miss (EPS -$0.07 vs -$0.06 est.). Real-time X sentiment positive on partnerships but volatility from auto cycle. Degenerate Stonks scores story durability and risk not price targets or financial advice." [X Link](https://x.com/anyuser/status/2021987655136031121) 2026-02-12T16:39Z [--] followers, [--] engagements "This is for the incredibly patient folks. $LTBR Degenerate Stonks Scorecard: 10/20 Lightbridge Corporation develops advanced nuclear fuel technology (Lightbridge Fuel) for existing reactors and small modular reactors aiming for enhanced safety economics and proliferation resistance. This is a pre-commercial nuclear innovation play. Recent irradiation testing start at Idaho National Lab (Nov 2025) Q3 [----] update with strong cash ($153M) and investor conferences (Jan 2026). But pre-revenue (no TTM income) deep losses (-$16.3M TTM -$4.1M Q3) R&D burn ($17M planned 2025) and long timelines" [X Link](https://x.com/anyuser/status/2021577055020765475) 2026-02-11T13:28Z [--] followers, [--] engagements "Who likes copper $FCX Freeport-McMoRan is the world's leading publicly traded copper producer with major operations in Grasberg (Indonesia) South America and U.S. porphyry deposits positioning it as a core electrification play amid surging demand for EVs grids and renewables. The narrative centers on recovering from Grasberg disruptions (e.g. [----] cave-in impact) while ramping leach initiatives for low-cost output; recent Q4 [----] beats (revenue $5.63B EPS $0.47) show resilience but [----] sales cut (3.4B lbs copper) tempers near-term growth amid supply tightness. Real-time X sentiment leans" [X Link](https://x.com/DegStonks/status/2018784665666981905) 2026-02-03T20:32Z [--] followers, [--] engagements "@trevor_hun_stoc Super early; super speculative; super interesting" [X Link](https://x.com/DegStonks/status/2021034381574316453) 2026-02-10T01:32Z [--] followers, [--] engagements "@futurist_lens @grok Very nice. I almost don't want to share the results before they get scored according to the DegenerateStonks methodology. However; $RKLB $LTBR $INDI $QBTS $NNOX" [X Link](https://x.com/DegStonks/status/2021297837129056488) 2026-02-10T18:58Z [--] followers, [---] engagements "$HIMS Degenerate Stonks Scorecard: 12/20 Boy oh boy. There are a lot of different ways to interpret anything to do with this one right now but here we go. Hims & Hers Health is a telehealth platform offering personalized wellness products (hair loss ED weight loss mental health skincare) with a growing focus on compounded GLP-1s (semaglutide) for weight loss amid branded shortages. They provide consumers access to affordable treatments but recent events have heavily pressured the stock. FDA scrutiny leading to withdrawal of low-cost oral semaglutide (Feb [--] 2026) Novo Nordisk patent" [X Link](https://x.com/anyuser/status/2023094985491366391) 2026-02-15T18:00Z [--] followers, [--] engagements "@CKCapitalxx It's certainly on our radar. This is how we scored in near the end of January. We look forward to scoring this one again in the future" [X Link](https://x.com/DegStonks/status/2023077415275381003) 2026-02-15T16:50Z [--] followers, [---] engagements "@Investinc_Intel There are some very interesting things going on with $HIMS. If not for the lawsuit this thing would probably have a pretty strong narrative around it heading into earnings" [X Link](https://x.com/DegStonks/status/2023094234291851397) 2026-02-15T17:57Z [--] followers, [---] engagements "$UEC Degenerate Stonks Scorecard: 16/20 Who else is big into nuclear power Imagine being in on this one at a $4 entry point (or better) a few years ago. Uranium Energy Corp. is a U.S.-focused uranium mining and exploration company with a portfolio of ISR (in-situ recovery) projects in Wyoming and Texas plus a significant physical uranium inventory (1.36M lbs as of mid-2025) and no debt. With the burgeoning nuclear renaissance and U.S. energy security UEC has a strong balance sheet ($321M cash/inventory/equities at July [--] 2025) recent sales (810000 lbs at $82.52/lb in H1 FY2025) Sweetwater" [X Link](https://x.com/anyuser/status/2023147236251635741) 2026-02-15T21:27Z [--] followers, [--] engagements "$UEC Degenerate Stonks Scorecard: 16/20 Who else is big into nuclear power Imagine being in on this one at a $4 entry point (or better) a few years ago. Uranium Energy Corp. is a U.S.-focused uranium mining and exploration company with a portfolio of ISR (in-situ recovery) projects in Wyoming and Texas plus a significant physical uranium inventory (1.36M lbs as of mid-2025) and no debt. With the burgeoning nuclear renaissance and U.S. energy security UEC has a strong balance sheet ($321M cash/inventory/equities at July [--] 2025) recent sales (810000 lbs at $82.52/lb in H1 FY2025) Sweetwater" [X Link](https://x.com/anyuser/status/2023147236251635741) 2026-02-15T21:27Z [--] followers, [--] engagements "$HIMS Degenerate Stonks Scorecard: 12/20 Boy oh boy. There are a lot of different ways to interpret anything to do with this one right now but here we go. Hims & Hers Health is a telehealth platform offering personalized wellness products (hair loss ED weight loss mental health skincare) with a growing focus on compounded GLP-1s (semaglutide) for weight loss amid branded shortages. They provide consumers access to affordable treatments but recent events have heavily pressured the stock. FDA scrutiny leading to withdrawal of low-cost oral semaglutide (Feb [--] 2026) Novo Nordisk patent" [X Link](https://x.com/anyuser/status/2023094985491366391) 2026-02-15T18:00Z [--] followers, [--] engagements "Well well well $ONCY. My how the turns have tabled. DegenerateStonks Scorecard: 13/20 When we first scored this in January we gave them a score of [--] and mentioned the risk associated with them. But the story was strong. Fast forward a bit and here we are. In case you aren't familiar with them; Oncolytics Biotech is a clinical-stage biotech developing REQORSA (oncolytic virus therapy) for non-small cell lung cancer (NSCLC) with Phase [--] Acclaim-1 data readout Q1 [----] and Acclaim-3 expansion (interim H2 2026). What seems to be fueling this jump in price is a recent cluster of insider buys (Feb" [X Link](https://x.com/anyuser/status/2022411923724066952) 2026-02-13T20:45Z [--] followers, [---] engagements "$INDI Degenerate Stonks Scorecard: 15/20 indie Semiconductor designs mixed-signal semiconductors for automotive ADAS in-cabin monitoring and emerging robotics/quantum markets. This is auto-tech with a $7.1B backlog and [----] $800M sales goal plus new emotion3D partnership (Mahindra EVs Feb 2026) and laser diode for quantum/automotive. Recent Q4 [----] earnings Feb [--] call pending but Q3 [----] miss (EPS -$0.07 vs -$0.06 est.). Real-time X sentiment positive on partnerships but volatility from auto cycle. Degenerate Stonks scores story durability and risk not price targets or financial advice." [X Link](https://x.com/anyuser/status/2021987655136031121) 2026-02-12T16:39Z [--] followers, [--] engagements "$RKLB Degenerate Stonks Scorecard: 17/20 Rocket Lab is a space launch and systems company with Electron (small-lift [--] launches in [----] record) and upcoming Neutron (medium-lift maiden flight targeted H1 2026). They have continued to deliver big on their promises and show ongoing durable growth and execution. Some of the major catalysts include record launches $816M U.S. Space Force prime contract (Tranche [--] satellites) defense prime evolution and Space Systems backlog conversion driving margins. Recent Q4 [----] preview points to beatable revenue ($130-140M est.) but Neutron risks (e.g. Stage" [X Link](https://x.com/anyuser/status/2021789634389299265) 2026-02-12T03:33Z [--] followers, [---] engagements "This is for the incredibly patient folks. $LTBR Degenerate Stonks Scorecard: 10/20 Lightbridge Corporation develops advanced nuclear fuel technology (Lightbridge Fuel) for existing reactors and small modular reactors aiming for enhanced safety economics and proliferation resistance. This is a pre-commercial nuclear innovation play. Recent irradiation testing start at Idaho National Lab (Nov 2025) Q3 [----] update with strong cash ($153M) and investor conferences (Jan 2026). But pre-revenue (no TTM income) deep losses (-$16.3M TTM -$4.1M Q3) R&D burn ($17M planned 2025) and long timelines" [X Link](https://x.com/anyuser/status/2021577055020765475) 2026-02-11T13:28Z [--] followers, [--] engagements "Well. This is interesting. Euphoria (@euphoria_fi) is cooking up a new way to trade - gamification to a new level. If interested this project is launching soon on MegaETH (Still early) Just joined the waitlist and it feels euphoric ✨ Join here 👇 https://euphoria.financeref_id=YTWZ2PFZG https://euphoria.financeref_id=YTWZ2PFZG" [X Link](https://x.com/anyuser/status/2021311121882239407) 2026-02-10T19:51Z [--] followers, [--] engagements "$RKLB is without doubt my current highest Space conviction for [----] - [----]. Here's why it can reach $205 and 3-4x: The MOAT nobodys talking about: $RKLB isnt just a launch company anymore. Theyre the ONLY vertically integrated space prime that controls STAGGERING 90% of their supply chain in-house. Think about what that means: They manufacture reaction wheels star trackers solar arrays AND launch the rocket Theyre the merchant supplier to the entire industry. They capture value on missions their competitors launch. It's IMPOSSIBLE to just build a competitor to a decade of flight heritage and" [X Link](https://x.com/anyuser/status/2020921724330561962) 2026-02-09T18:04Z 13.7K followers, 28.1K engagements "$TE is one of my highest conviction stocks into [----] WHAT THE MARKET THINKS: The market is pricing T1 Energy as a cyclical capital-intensive solar assembler. But this narrative is outdated TE is building a vertically integrated U.S. solar + battery supply chain at a time when domestic sourcing is a strategic priority The CORE MOAT: TE isnt just making modules its systematically owning manufacturing from cells to finished product in the US G1 Dallas (solar modules) is scaling production ahead of plan G2 Austin (solar cell fabrication) is under construction with Phase [--] targeted for Q4 2026" [X Link](https://x.com/anyuser/status/2021215112770498903) 2026-02-10T13:30Z 13.6K followers, 12.9K engagements "$CRBAF Degenerate Stonks Scorecard: 8/20 Agereh Technologies is a software company developing AI-powered solutions originally for automotive marketplaces (formerly Carbeeza Inc.) but expanding into intelligent transportation systems (ITS) with wireless sensors like HeadCounter (passenger tracking) MapNTrack (asset visibility) and the newly launched Smart Door Sensor (door/activity monitoring for transit hubs). What's going on with them now is an early pivot to real-time operational intelligence for transportation with a recent consulting agreement with Hillside C&M ($50K/month for awareness)." [X Link](https://x.com/anyuser/status/2021035220321882264) 2026-02-10T01:35Z [--] followers, [--] engagements "$BITF Degenerate Stonks Scorecard: 10/20 Bitfarms is pivoting from Bitcoin mining to AI/HPC infrastructure with U.S. redomiciliation (planned April [----] rebrand to Keel Infrastructure) strong liquidity ($698M net as of Feb 2026) and HPC site conversions (e.g. Washington 18MW to GB300 GPUs). The story and excitement are around a cost-advantaged (hydro power in Quebec/PA) hybrid play that still facing challenges: postponed guidance rising leverage/capex EBITDA declines liquidity risks (1 year cash runway highlighted) regulatory delays in crypto market structure and operational hurdles in" [X Link](https://x.com/anyuser/status/2020532480428650586) 2026-02-08T16:17Z [--] followers, [---] engagements "$JSDA Degenerate Stonks Scorecard: 9/20 Jones Soda is a craft beverage company expanding from premium sodas into cannabis-infused drinks (Mary Jones brand) energy shots and THC gummies/syrups targeting retail growth (e.g. Walmart Kroger expansions). Turnaround stories like this are fascinating. Jones Soda is able to pull at the heart strings of nostalgia with some of their limited edition set releases (such as the Fallout one) and now they've managed to pivot into the cannabis market. They do have some positive momentum with recent Q3 [----] beats (revenue $4.6M +17% YoY gross margin 31.4%) but" [X Link](https://x.com/anyuser/status/2020528550093177288) 2026-02-08T16:02Z [--] followers, [--] engagements "$CIFR Degenerate Stonks Scorecard: 16/20 Cipher Mining is pivoting from Bitcoin mining to AI/HPC data centers with large-scale colocation deals (e.g. Amazon pre-lease for Black Pearl 300MW Google/others contributing to $8.5B contracted revenue over 10+ years). The new story behind them is a high-conviction AI infrastructure play: recent $2B senior secured notes (Feb 2026) fund Black Pearl completion strong Q3 [----] crypto revenue tripled YoY and HPC ramp targets [----] delivery. Risks still remain however. Legacy mining losses high debt from funding execution on buildouts and valuation" [X Link](https://x.com/anyuser/status/2020242570333339668) 2026-02-07T21:05Z [--] followers, [---] engagements "$GNPX Degenerate Stonks Scorecard: 7/20 Who likes to play in the biotech sandbox Genprex is a clinical-stage gene therapy company developing Oncoprex (REQORSA) for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) with Acclaim-1 Phase [--] data readout targeted Q1 [----] and Acclaim-3 expansion (interim analysis H2 2026). As far as biotech moonshots go this one has FDA Fast Track/Orphan designations but is pre-revenue (no TTM income) with deep losses (-$7.2M Q3 [----] -$25M TTM) cash burn (runway into Q2 [----] post-$3.1M raise) and execution risks amid clinical timelines and" [X Link](https://x.com/anyuser/status/2020229326973858290) 2026-02-07T20:13Z [--] followers, [---] engagements "$CRS Degenerate Stonks Scorecard: 17/20 Carpenter Technology is a leading producer of premium specialty alloys and materials for aerospace defense medical and energy sectors with a focus on high-performance solutions like titanium and superalloys. The CRS story is one of a resilient materials play benefiting from aerospace/defense tailwinds (e.g. Boeing/GE ramps) with recent Q2 FY2026 beats (revenue $1.1B +19% YoY EPS $1.75 beat estimates) and raised FY2026 EBITDA guidance ($735-775M). There are still cyclical risks remaining such as: modest growth outlook (FY2026 revenue est. $4.2B +8%)" [X Link](https://x.com/anyuser/status/2020221510514844029) 2026-02-07T19:41Z [--] followers, [--] engagements "$FFAI Degenerate Stonks Scorecard: 11/20 We can all agree that robots are cool. Useful (and affordable) robots are even cooler. This one is really interesting and shows real promise and possible utility; but very fragile overall right now. The $10M equity investment from AIxCrypto (AIXC) via SEC agreement (Jan [--] 2026) provides short-term liquidity but introduces explicit dilution risks with anti-dilution true-up shares. Then there is the non-exclusive strategic partnership with AIXC exploring blockchain integration in robotics (e.g. decentralized identity on-chain settlements) which aligns" [X Link](https://x.com/anyuser/status/2019998619022078435) 2026-02-07T04:56Z [--] followers, [---] engagements "If you didnt sell any stocks during this brutal week give yourself some credit. Discipline and patience are what separate investors from traders. That was a crazy market" [X Link](https://x.com/anyuser/status/2019786706744905811) 2026-02-06T14:54Z 17K followers, 59.6K engagements "$UAMY Offtake Poker ✍ Radersburg Mill (Jan '26) gives USAC in-house domestic ore concentration but the real play is capacity and quality. Once Thompson Falls expansion completes leadership shifts focus to scaling Smelter #2 in Madero. Then what CEO teased at IDEAS Conference last November that Idaho Smelter #3 is being mapped to anchor a HUGE new strategic contract. Hatch/INL's hydromet process at Radersburg means low-grade antimony (10% Sb) now meets mil-spec standards. Deposits that folded pre-flop are back in the hand. Confirmed Partners: ✅ $USAS Americas Gold & Silver Producing NOW 561K" [X Link](https://x.com/anyuser/status/2019490997491687482) 2026-02-05T19:19Z [----] followers, [----] engagements "Tell us some stocks you are looking at or are wondering about. We can give you the story and score behind them. No price predictions. No charts. Just the story and momentum behind it. #stocks #stockmarket" [X Link](https://x.com/anyuser/status/2019588608571965603) 2026-02-06T01:47Z [--] followers, [--] engagements "This is why it is so very important to truly know what you are holding short what you are holding long and what your risk appetite is. The stock market is NOT crashing. The S&P is down less than 2%. Your portfolio sinking means you have exposure to higher volatility assets. These assets provide the potential high growth but also hold more downside risk as we are seeing. If you want mega growth you have to https://t.co/4iwOaKKpjh The stock market is NOT crashing. The S&P is down less than 2%. Your portfolio sinking means you have exposure to higher volatility assets. These assets provide the" [X Link](https://x.com/anyuser/status/2019444539212111888) 2026-02-05T16:14Z [--] followers, [--] engagements "The stock market is NOT crashing. The S&P is down less than 2%. Your portfolio sinking means you have exposure to higher volatility assets. These assets provide the potential high growth but also hold more downside risk as we are seeing. If you want mega growth you have to have the nuts for steeper pullbacks. That is the game you sign up to play. https://twitter.com/i/web/status/2019240137956241839 https://twitter.com/i/web/status/2019240137956241839" [X Link](https://x.com/anyuser/status/2019240137956241839) 2026-02-05T02:42Z 48.9K followers, 289.8K engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@DegStonks DegenerateStonksDegenerateStonks posts on X about play, company, strong, this is the most. They currently have [------] followers and [--] posts still getting attention that total [-----] engagements in the last [--] hours.
Social category influence stocks finance cryptocurrencies automotive brands countries technology brands
Social topic influence play, company, strong, this is, mining, growth, $cifr, we are, solar, liquidity
Top accounts mentioned or mentioned by @capitansteveo @ckcapitalxx @trevorhunstoc @kurtgibbonsx @ap_redcoldriver @juggmanguwop @hurdleratepod @strive @strategy @t1energy @thomasjames1 @electroncowboy @chamath @crusoeai @futuristlens @grok @investincintel @euphoriafi @red81110245 @trevor_hun_stoc
Top assets mentioned Cipher Mining Inc. Common Stock (CIFR) Bitcoin (BTC) Rocket Lab USA, Inc. Common Stock (RKLB) Faraday Future Intelligent Electric Inc. Common Stock (FFAI) Hims & Hers Health, Inc. (HIMS) AB (prev. Newton) (AB) FTC Solar, Inc. (FTCI) retard to retired (R/R) Carpenter Technology Corp (CRS) Kroger Co (KR) Bitfarms Ltd. (BITF) Uranium Energy Corp. (UEC)
Top posts by engagements in the last [--] hours
"$AB Degenerate Stonks Score: [--] / [--] Tier: Durable but Unexciting AllianceBernstein is a cash-generating asset manager with low dilution risk and a valuation focused on income and stability. This is not a hyper-growth story but it is a survivable one. Recent leadership changes and reduced short interest support sentiment but upside is incremental rather than explosive. New attention may fall on #AllianceBernstein because of recently disclosed positions taken by #NancyPelosi. This score reflects durability and risk; not price targets or advice."
X Link 2026-01-26T16:45Z [--] followers, [----] engagements
"Well well well $ONCY. My how the turns have tabled. DegenerateStonks Scorecard: 13/20 When we first scored this in January we gave them a score of [--] and mentioned the risk associated with them. But the story was strong. Fast forward a bit and here we are. In case you aren't familiar with them; Oncolytics Biotech is a clinical-stage biotech developing REQORSA (oncolytic virus therapy) for non-small cell lung cancer (NSCLC) with Phase [--] Acclaim-1 data readout Q1 [----] and Acclaim-3 expansion (interim H2 2026). What seems to be fueling this jump in price is a recent cluster of insider buys (Feb"
X Link 2026-02-13T20:45Z [--] followers, [---] engagements
"Love the work y'all do over there. Been a great inspiration for a lot of folks. $AB scores as durable not explosive from how we're looking at it. They have strong cash flows low dilution risk and a valuation built around income rather than growth. The trade fits a stability profile more than a momentum or speculative one. Strong fundamentals even if a 'boring' company. There's a reason elected officials go after stocks like this. https://twitter.com/i/web/status/2015827508998889562 https://twitter.com/i/web/status/2015827508998889562"
X Link 2026-01-26T16:41Z [--] followers, [----] engagements
"@JuggManGuwop @HurdleRatePod @strive @Strategy And that's what makes them so darn interesting. =)"
X Link 2026-01-29T04:47Z [--] followers, [--] engagements
"$INTC score is held back primarily by two areas: Financial Trajectory (2/4) Product & Execution (2/4) Financial Trajectory: Intels recent results show improvement but managements cautious [----] outlook highlights that recovery is still uneven. Revenue and profitability are stabilizing from a weak period not accelerating from strength. This is a transition phase not a confirmed growth cycle. Product & Execution: Intels roadmap and foundry ambitions are credible but execution consistency remains the key risk. The company is mid-turnaround requiring sustained delivery across manufacturing and"
X Link 2026-01-31T16:17Z [--] followers, [--] engagements
"Hard agree on that. Here's one we recently scored. $FTCI #solarindustries #solarpower Solar is not A source of energy it is THE source of energy Solar is not A source of energy it is THE source of energy"
X Link 2026-01-31T22:28Z [--] followers, [---] engagements
"$FTCI FTC Solar is in an interesting position to deliver on legitimate potential. They provide single-axis solar trackers software (Voyager) and engineering services for utility-scale projects optimizing yield in large solar farms. Not only are they a US-based solar company they also benefit greatly from strong domestic incentives. Recent revenue growth shows real promise on the horizon for investors; strong Q3 [----] revenue of $26M (+157% YoY beat guidance). This is their first positive gross margin since [----] (6-7%) and have a backlog of projects worth up to $462M. Q4 guidance was $30-$35M"
X Link 2026-01-31T22:34Z [--] followers, [--] engagements
"$TE scores strongest in one primary area on the Degenerate Stonks Scorecard: Market & Sector (3/4) Market & Sector: T1 Energy operates in energy and infrastructure-adjacent markets that benefit from long-term structural demand. Electrification power generation and energy security remain durable macro themes. From a top-down perspective the market opportunity itself is real and supportive. This score reflects macro tailwinds not company execution. Strong markets create opportunity. They dont guarantee outcomes. https://twitter.com/i/web/status/2018018761463267503"
X Link 2026-02-01T17:49Z [--] followers, [---] engagements
"$MP DegenerateStonks Scorecard: 13/20 MP Materials owns and operates Mountain Pass America's only scaled rare earth mine/processor producing NdPr oxide and advancing to full mine-to-magnet integration with its Fort Worth facility (magnets Q1 2026). The narrative focuses on U.S. supply chain resilience amid China dominance with Q4 [----] results due Feb [--] (est. EPS $0.10) but [----] challenges (revenue down 50% Q3 losses) and policy shifts temper momentum. Real-time X sentiment mixed-positive on government stakes (15%) and DoD deals but sell-offs noted amid refining tech concerns. #mpmaterials"
X Link 2026-02-03T23:09Z [--] followers, [--] engagements
"$NVX DegenerateStonks Scorecard: 10/20 NOVONIX is a battery tech/materials firm developing North America's first synthetic graphite anode production (Riverside facility mass prod [----] for industrial [----] for batteries) with testing equipment/services as cash flow bridge. Narrative: IRA-compliant supply chain for EVs but delays (Panasonic H2 [----] Stellantis termination) pre-revenue status (TTM $5.93M) losses (-$66M) and funding needs amid execution push. X sentiment positive on first-mover edge but volatility concerns. Pre-production stories hinge on milestones. Making the potential real but"
X Link 2026-02-04T17:40Z [--] followers, [---] engagements
"By being patient and disciplined. This is where knowing what the story is behind a stock and understanding how strong that story is can pay off over the long haul. Here are a few worth keeping an eye on. Especially as the dust begins to settle in certain sectors. $NBIS $RR $VELO https://twitter.com/i/web/status/2019612523167641963 https://twitter.com/i/web/status/2019612523167641963"
X Link 2026-02-06T03:22Z [--] followers, [----] engagements
"@T1_Energy Seems to be a bright future ahead"
X Link 2026-02-06T03:44Z [--] followers, [--] engagements
"$FFAI Degenerate Stonks Scorecard: 11/20 We can all agree that robots are cool. Useful (and affordable) robots are even cooler. This one is really interesting and shows real promise and possible utility; but very fragile overall right now. The $10M equity investment from AIxCrypto (AIXC) via SEC agreement (Jan [--] 2026) provides short-term liquidity but introduces explicit dilution risks with anti-dilution true-up shares. Then there is the non-exclusive strategic partnership with AIXC exploring blockchain integration in robotics (e.g. decentralized identity on-chain settlements) which aligns"
X Link 2026-02-07T04:56Z [--] followers, [---] engagements
"@Thomas_james_1 $FFAI & $RR are two others worth a close watch. Depending on your risk appetite"
X Link 2026-02-07T17:03Z [--] followers, [---] engagements
"$CRS Degenerate Stonks Scorecard: 17/20 Carpenter Technology is a leading producer of premium specialty alloys and materials for aerospace defense medical and energy sectors with a focus on high-performance solutions like titanium and superalloys. The CRS story is one of a resilient materials play benefiting from aerospace/defense tailwinds (e.g. Boeing/GE ramps) with recent Q2 FY2026 beats (revenue $1.1B +19% YoY EPS $1.75 beat estimates) and raised FY2026 EBITDA guidance ($735-775M). There are still cyclical risks remaining such as: modest growth outlook (FY2026 revenue est. $4.2B +8%)"
X Link 2026-02-07T19:41Z [--] followers, [--] engagements
"$GNPX Degenerate Stonks Scorecard: 7/20 Who likes to play in the biotech sandbox Genprex is a clinical-stage gene therapy company developing Oncoprex (REQORSA) for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) with Acclaim-1 Phase [--] data readout targeted Q1 [----] and Acclaim-3 expansion (interim analysis H2 2026). As far as biotech moonshots go this one has FDA Fast Track/Orphan designations but is pre-revenue (no TTM income) with deep losses (-$7.2M Q3 [----] -$25M TTM) cash burn (runway into Q2 [----] post-$3.1M raise) and execution risks amid clinical timelines and"
X Link 2026-02-07T20:13Z [--] followers, [---] engagements
"@CapitanSteveo We wouldn't necessarily view one as being 'safer' than the other due to the speculative nature of their sector but based on the story backing each - we'd give the edge to $CIFR. They are better set up to succeed long-term especially with their recent pivot"
X Link 2026-02-07T21:02Z [--] followers, [---] engagements
"$CIFR Degenerate Stonks Scorecard: 16/20 Cipher Mining is pivoting from Bitcoin mining to AI/HPC data centers with large-scale colocation deals (e.g. Amazon pre-lease for Black Pearl 300MW Google/others contributing to $8.5B contracted revenue over 10+ years). The new story behind them is a high-conviction AI infrastructure play: recent $2B senior secured notes (Feb 2026) fund Black Pearl completion strong Q3 [----] crypto revenue tripled YoY and HPC ramp targets [----] delivery. Risks still remain however. Legacy mining losses high debt from funding execution on buildouts and valuation"
X Link 2026-02-07T21:05Z [--] followers, [---] engagements
"Seems there may have been a temporary trading app glitch (e.g. seen on Thinkorswim snapping back quickly) not real fundamentals or a setup for a squeeze. Current data shows [-----] to 10M shares available to borrow across brokers with short interest at 40.11M (20.23% of float) and elevated borrow fees ranging 10.57-12.88%. So elevated but not extreme (e.g. not 100% like true squeezes). Short ratio is [--] days to cover implying no immediate pressure. Plus keep in mind that enough people still need to believe in the story enough to keep it going strong."
X Link 2026-02-08T02:43Z [--] followers, [---] engagements
"@CKCapitalxx $CIFR is an interesting one with this pivot of theirs. It scores well and has a strong story and momentum"
X Link 2026-02-08T04:52Z [--] followers, [---] engagements
"$JSDA Degenerate Stonks Scorecard: 9/20 Jones Soda is a craft beverage company expanding from premium sodas into cannabis-infused drinks (Mary Jones brand) energy shots and THC gummies/syrups targeting retail growth (e.g. Walmart Kroger expansions). Turnaround stories like this are fascinating. Jones Soda is able to pull at the heart strings of nostalgia with some of their limited edition set releases (such as the Fallout one) and now they've managed to pivot into the cannabis market. They do have some positive momentum with recent Q3 [----] beats (revenue $4.6M +17% YoY gross margin 31.4%) but"
X Link 2026-02-08T16:02Z [--] followers, [--] engagements
"$BITF Degenerate Stonks Scorecard: 10/20 Bitfarms is pivoting from Bitcoin mining to AI/HPC infrastructure with U.S. redomiciliation (planned April [----] rebrand to Keel Infrastructure) strong liquidity ($698M net as of Feb 2026) and HPC site conversions (e.g. Washington 18MW to GB300 GPUs). The story and excitement are around a cost-advantaged (hydro power in Quebec/PA) hybrid play that still facing challenges: postponed guidance rising leverage/capex EBITDA declines liquidity risks (1 year cash runway highlighted) regulatory delays in crypto market structure and operational hurdles in"
X Link 2026-02-08T16:17Z [--] followers, [---] engagements
"@CapitanSteveo Not as high as $CIFR but there's still something here worth following"
X Link 2026-02-08T16:18Z [--] followers, [--] engagements
"@trevor_hun_stoc Well. Those that are in already are probably pleased. ;-)"
X Link 2026-02-10T13:10Z [--] followers, [--] engagements
"@Electron_Cowboy @chamath @CrusoeAI What are your thoughts on carbon nanotubes possibly being scalable and cost efficient enough to be a legitimate alternative to copper in the future"
X Link 2026-02-11T15:21Z [--] followers, [---] engagements
"$RKLB Degenerate Stonks Scorecard: 17/20 Rocket Lab is a space launch and systems company with Electron (small-lift [--] launches in [----] record) and upcoming Neutron (medium-lift maiden flight targeted H1 2026). They have continued to deliver big on their promises and show ongoing durable growth and execution. Some of the major catalysts include record launches $816M U.S. Space Force prime contract (Tranche [--] satellites) defense prime evolution and Space Systems backlog conversion driving margins. Recent Q4 [----] preview points to beatable revenue ($130-140M est.) but Neutron risks (e.g. Stage"
X Link 2026-02-12T03:33Z [--] followers, [---] engagements
"$INDI Degenerate Stonks Scorecard: 15/20 indie Semiconductor designs mixed-signal semiconductors for automotive ADAS in-cabin monitoring and emerging robotics/quantum markets. This is auto-tech with a $7.1B backlog and [----] $800M sales goal plus new emotion3D partnership (Mahindra EVs Feb 2026) and laser diode for quantum/automotive. Recent Q4 [----] earnings Feb [--] call pending but Q3 [----] miss (EPS -$0.07 vs -$0.06 est.). Real-time X sentiment positive on partnerships but volatility from auto cycle. Degenerate Stonks scores story durability and risk not price targets or financial advice."
X Link 2026-02-12T16:39Z [--] followers, [--] engagements
"This is for the incredibly patient folks. $LTBR Degenerate Stonks Scorecard: 10/20 Lightbridge Corporation develops advanced nuclear fuel technology (Lightbridge Fuel) for existing reactors and small modular reactors aiming for enhanced safety economics and proliferation resistance. This is a pre-commercial nuclear innovation play. Recent irradiation testing start at Idaho National Lab (Nov 2025) Q3 [----] update with strong cash ($153M) and investor conferences (Jan 2026). But pre-revenue (no TTM income) deep losses (-$16.3M TTM -$4.1M Q3) R&D burn ($17M planned 2025) and long timelines"
X Link 2026-02-11T13:28Z [--] followers, [--] engagements
"Who likes copper $FCX Freeport-McMoRan is the world's leading publicly traded copper producer with major operations in Grasberg (Indonesia) South America and U.S. porphyry deposits positioning it as a core electrification play amid surging demand for EVs grids and renewables. The narrative centers on recovering from Grasberg disruptions (e.g. [----] cave-in impact) while ramping leach initiatives for low-cost output; recent Q4 [----] beats (revenue $5.63B EPS $0.47) show resilience but [----] sales cut (3.4B lbs copper) tempers near-term growth amid supply tightness. Real-time X sentiment leans"
X Link 2026-02-03T20:32Z [--] followers, [--] engagements
"@trevor_hun_stoc Super early; super speculative; super interesting"
X Link 2026-02-10T01:32Z [--] followers, [--] engagements
"@futurist_lens @grok Very nice. I almost don't want to share the results before they get scored according to the DegenerateStonks methodology. However; $RKLB $LTBR $INDI $QBTS $NNOX"
X Link 2026-02-10T18:58Z [--] followers, [---] engagements
"$HIMS Degenerate Stonks Scorecard: 12/20 Boy oh boy. There are a lot of different ways to interpret anything to do with this one right now but here we go. Hims & Hers Health is a telehealth platform offering personalized wellness products (hair loss ED weight loss mental health skincare) with a growing focus on compounded GLP-1s (semaglutide) for weight loss amid branded shortages. They provide consumers access to affordable treatments but recent events have heavily pressured the stock. FDA scrutiny leading to withdrawal of low-cost oral semaglutide (Feb [--] 2026) Novo Nordisk patent"
X Link 2026-02-15T18:00Z [--] followers, [--] engagements
"@CKCapitalxx It's certainly on our radar. This is how we scored in near the end of January. We look forward to scoring this one again in the future"
X Link 2026-02-15T16:50Z [--] followers, [---] engagements
"@Investinc_Intel There are some very interesting things going on with $HIMS. If not for the lawsuit this thing would probably have a pretty strong narrative around it heading into earnings"
X Link 2026-02-15T17:57Z [--] followers, [---] engagements
"$UEC Degenerate Stonks Scorecard: 16/20 Who else is big into nuclear power Imagine being in on this one at a $4 entry point (or better) a few years ago. Uranium Energy Corp. is a U.S.-focused uranium mining and exploration company with a portfolio of ISR (in-situ recovery) projects in Wyoming and Texas plus a significant physical uranium inventory (1.36M lbs as of mid-2025) and no debt. With the burgeoning nuclear renaissance and U.S. energy security UEC has a strong balance sheet ($321M cash/inventory/equities at July [--] 2025) recent sales (810000 lbs at $82.52/lb in H1 FY2025) Sweetwater"
X Link 2026-02-15T21:27Z [--] followers, [--] engagements
"$UEC Degenerate Stonks Scorecard: 16/20 Who else is big into nuclear power Imagine being in on this one at a $4 entry point (or better) a few years ago. Uranium Energy Corp. is a U.S.-focused uranium mining and exploration company with a portfolio of ISR (in-situ recovery) projects in Wyoming and Texas plus a significant physical uranium inventory (1.36M lbs as of mid-2025) and no debt. With the burgeoning nuclear renaissance and U.S. energy security UEC has a strong balance sheet ($321M cash/inventory/equities at July [--] 2025) recent sales (810000 lbs at $82.52/lb in H1 FY2025) Sweetwater"
X Link 2026-02-15T21:27Z [--] followers, [--] engagements
"$HIMS Degenerate Stonks Scorecard: 12/20 Boy oh boy. There are a lot of different ways to interpret anything to do with this one right now but here we go. Hims & Hers Health is a telehealth platform offering personalized wellness products (hair loss ED weight loss mental health skincare) with a growing focus on compounded GLP-1s (semaglutide) for weight loss amid branded shortages. They provide consumers access to affordable treatments but recent events have heavily pressured the stock. FDA scrutiny leading to withdrawal of low-cost oral semaglutide (Feb [--] 2026) Novo Nordisk patent"
X Link 2026-02-15T18:00Z [--] followers, [--] engagements
"Well well well $ONCY. My how the turns have tabled. DegenerateStonks Scorecard: 13/20 When we first scored this in January we gave them a score of [--] and mentioned the risk associated with them. But the story was strong. Fast forward a bit and here we are. In case you aren't familiar with them; Oncolytics Biotech is a clinical-stage biotech developing REQORSA (oncolytic virus therapy) for non-small cell lung cancer (NSCLC) with Phase [--] Acclaim-1 data readout Q1 [----] and Acclaim-3 expansion (interim H2 2026). What seems to be fueling this jump in price is a recent cluster of insider buys (Feb"
X Link 2026-02-13T20:45Z [--] followers, [---] engagements
"$INDI Degenerate Stonks Scorecard: 15/20 indie Semiconductor designs mixed-signal semiconductors for automotive ADAS in-cabin monitoring and emerging robotics/quantum markets. This is auto-tech with a $7.1B backlog and [----] $800M sales goal plus new emotion3D partnership (Mahindra EVs Feb 2026) and laser diode for quantum/automotive. Recent Q4 [----] earnings Feb [--] call pending but Q3 [----] miss (EPS -$0.07 vs -$0.06 est.). Real-time X sentiment positive on partnerships but volatility from auto cycle. Degenerate Stonks scores story durability and risk not price targets or financial advice."
X Link 2026-02-12T16:39Z [--] followers, [--] engagements
"$RKLB Degenerate Stonks Scorecard: 17/20 Rocket Lab is a space launch and systems company with Electron (small-lift [--] launches in [----] record) and upcoming Neutron (medium-lift maiden flight targeted H1 2026). They have continued to deliver big on their promises and show ongoing durable growth and execution. Some of the major catalysts include record launches $816M U.S. Space Force prime contract (Tranche [--] satellites) defense prime evolution and Space Systems backlog conversion driving margins. Recent Q4 [----] preview points to beatable revenue ($130-140M est.) but Neutron risks (e.g. Stage"
X Link 2026-02-12T03:33Z [--] followers, [---] engagements
"This is for the incredibly patient folks. $LTBR Degenerate Stonks Scorecard: 10/20 Lightbridge Corporation develops advanced nuclear fuel technology (Lightbridge Fuel) for existing reactors and small modular reactors aiming for enhanced safety economics and proliferation resistance. This is a pre-commercial nuclear innovation play. Recent irradiation testing start at Idaho National Lab (Nov 2025) Q3 [----] update with strong cash ($153M) and investor conferences (Jan 2026). But pre-revenue (no TTM income) deep losses (-$16.3M TTM -$4.1M Q3) R&D burn ($17M planned 2025) and long timelines"
X Link 2026-02-11T13:28Z [--] followers, [--] engagements
"Well. This is interesting. Euphoria (@euphoria_fi) is cooking up a new way to trade - gamification to a new level. If interested this project is launching soon on MegaETH (Still early) Just joined the waitlist and it feels euphoric ✨ Join here 👇 https://euphoria.financeref_id=YTWZ2PFZG https://euphoria.financeref_id=YTWZ2PFZG"
X Link 2026-02-10T19:51Z [--] followers, [--] engagements
"$RKLB is without doubt my current highest Space conviction for [----] - [----]. Here's why it can reach $205 and 3-4x: The MOAT nobodys talking about: $RKLB isnt just a launch company anymore. Theyre the ONLY vertically integrated space prime that controls STAGGERING 90% of their supply chain in-house. Think about what that means: They manufacture reaction wheels star trackers solar arrays AND launch the rocket Theyre the merchant supplier to the entire industry. They capture value on missions their competitors launch. It's IMPOSSIBLE to just build a competitor to a decade of flight heritage and"
X Link 2026-02-09T18:04Z 13.7K followers, 28.1K engagements
"$TE is one of my highest conviction stocks into [----] WHAT THE MARKET THINKS: The market is pricing T1 Energy as a cyclical capital-intensive solar assembler. But this narrative is outdated TE is building a vertically integrated U.S. solar + battery supply chain at a time when domestic sourcing is a strategic priority The CORE MOAT: TE isnt just making modules its systematically owning manufacturing from cells to finished product in the US G1 Dallas (solar modules) is scaling production ahead of plan G2 Austin (solar cell fabrication) is under construction with Phase [--] targeted for Q4 2026"
X Link 2026-02-10T13:30Z 13.6K followers, 12.9K engagements
"$CRBAF Degenerate Stonks Scorecard: 8/20 Agereh Technologies is a software company developing AI-powered solutions originally for automotive marketplaces (formerly Carbeeza Inc.) but expanding into intelligent transportation systems (ITS) with wireless sensors like HeadCounter (passenger tracking) MapNTrack (asset visibility) and the newly launched Smart Door Sensor (door/activity monitoring for transit hubs). What's going on with them now is an early pivot to real-time operational intelligence for transportation with a recent consulting agreement with Hillside C&M ($50K/month for awareness)."
X Link 2026-02-10T01:35Z [--] followers, [--] engagements
"$BITF Degenerate Stonks Scorecard: 10/20 Bitfarms is pivoting from Bitcoin mining to AI/HPC infrastructure with U.S. redomiciliation (planned April [----] rebrand to Keel Infrastructure) strong liquidity ($698M net as of Feb 2026) and HPC site conversions (e.g. Washington 18MW to GB300 GPUs). The story and excitement are around a cost-advantaged (hydro power in Quebec/PA) hybrid play that still facing challenges: postponed guidance rising leverage/capex EBITDA declines liquidity risks (1 year cash runway highlighted) regulatory delays in crypto market structure and operational hurdles in"
X Link 2026-02-08T16:17Z [--] followers, [---] engagements
"$JSDA Degenerate Stonks Scorecard: 9/20 Jones Soda is a craft beverage company expanding from premium sodas into cannabis-infused drinks (Mary Jones brand) energy shots and THC gummies/syrups targeting retail growth (e.g. Walmart Kroger expansions). Turnaround stories like this are fascinating. Jones Soda is able to pull at the heart strings of nostalgia with some of their limited edition set releases (such as the Fallout one) and now they've managed to pivot into the cannabis market. They do have some positive momentum with recent Q3 [----] beats (revenue $4.6M +17% YoY gross margin 31.4%) but"
X Link 2026-02-08T16:02Z [--] followers, [--] engagements
"$CIFR Degenerate Stonks Scorecard: 16/20 Cipher Mining is pivoting from Bitcoin mining to AI/HPC data centers with large-scale colocation deals (e.g. Amazon pre-lease for Black Pearl 300MW Google/others contributing to $8.5B contracted revenue over 10+ years). The new story behind them is a high-conviction AI infrastructure play: recent $2B senior secured notes (Feb 2026) fund Black Pearl completion strong Q3 [----] crypto revenue tripled YoY and HPC ramp targets [----] delivery. Risks still remain however. Legacy mining losses high debt from funding execution on buildouts and valuation"
X Link 2026-02-07T21:05Z [--] followers, [---] engagements
"$GNPX Degenerate Stonks Scorecard: 7/20 Who likes to play in the biotech sandbox Genprex is a clinical-stage gene therapy company developing Oncoprex (REQORSA) for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) with Acclaim-1 Phase [--] data readout targeted Q1 [----] and Acclaim-3 expansion (interim analysis H2 2026). As far as biotech moonshots go this one has FDA Fast Track/Orphan designations but is pre-revenue (no TTM income) with deep losses (-$7.2M Q3 [----] -$25M TTM) cash burn (runway into Q2 [----] post-$3.1M raise) and execution risks amid clinical timelines and"
X Link 2026-02-07T20:13Z [--] followers, [---] engagements
"$CRS Degenerate Stonks Scorecard: 17/20 Carpenter Technology is a leading producer of premium specialty alloys and materials for aerospace defense medical and energy sectors with a focus on high-performance solutions like titanium and superalloys. The CRS story is one of a resilient materials play benefiting from aerospace/defense tailwinds (e.g. Boeing/GE ramps) with recent Q2 FY2026 beats (revenue $1.1B +19% YoY EPS $1.75 beat estimates) and raised FY2026 EBITDA guidance ($735-775M). There are still cyclical risks remaining such as: modest growth outlook (FY2026 revenue est. $4.2B +8%)"
X Link 2026-02-07T19:41Z [--] followers, [--] engagements
"$FFAI Degenerate Stonks Scorecard: 11/20 We can all agree that robots are cool. Useful (and affordable) robots are even cooler. This one is really interesting and shows real promise and possible utility; but very fragile overall right now. The $10M equity investment from AIxCrypto (AIXC) via SEC agreement (Jan [--] 2026) provides short-term liquidity but introduces explicit dilution risks with anti-dilution true-up shares. Then there is the non-exclusive strategic partnership with AIXC exploring blockchain integration in robotics (e.g. decentralized identity on-chain settlements) which aligns"
X Link 2026-02-07T04:56Z [--] followers, [---] engagements
"If you didnt sell any stocks during this brutal week give yourself some credit. Discipline and patience are what separate investors from traders. That was a crazy market"
X Link 2026-02-06T14:54Z 17K followers, 59.6K engagements
"$UAMY Offtake Poker ✍ Radersburg Mill (Jan '26) gives USAC in-house domestic ore concentration but the real play is capacity and quality. Once Thompson Falls expansion completes leadership shifts focus to scaling Smelter #2 in Madero. Then what CEO teased at IDEAS Conference last November that Idaho Smelter #3 is being mapped to anchor a HUGE new strategic contract. Hatch/INL's hydromet process at Radersburg means low-grade antimony (10% Sb) now meets mil-spec standards. Deposits that folded pre-flop are back in the hand. Confirmed Partners: ✅ $USAS Americas Gold & Silver Producing NOW 561K"
X Link 2026-02-05T19:19Z [----] followers, [----] engagements
"Tell us some stocks you are looking at or are wondering about. We can give you the story and score behind them. No price predictions. No charts. Just the story and momentum behind it. #stocks #stockmarket"
X Link 2026-02-06T01:47Z [--] followers, [--] engagements
"This is why it is so very important to truly know what you are holding short what you are holding long and what your risk appetite is. The stock market is NOT crashing. The S&P is down less than 2%. Your portfolio sinking means you have exposure to higher volatility assets. These assets provide the potential high growth but also hold more downside risk as we are seeing. If you want mega growth you have to https://t.co/4iwOaKKpjh The stock market is NOT crashing. The S&P is down less than 2%. Your portfolio sinking means you have exposure to higher volatility assets. These assets provide the"
X Link 2026-02-05T16:14Z [--] followers, [--] engagements
"The stock market is NOT crashing. The S&P is down less than 2%. Your portfolio sinking means you have exposure to higher volatility assets. These assets provide the potential high growth but also hold more downside risk as we are seeing. If you want mega growth you have to have the nuts for steeper pullbacks. That is the game you sign up to play. https://twitter.com/i/web/status/2019240137956241839 https://twitter.com/i/web/status/2019240137956241839"
X Link 2026-02-05T02:42Z 48.9K followers, 289.8K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::DegStonks